Vaccitech Reports Interim Efficacy Analysts In Phase 1b/2a Clinical Study In Chronic HBV; Says Data Demonstrated ‘Noted Changes’ In Surface Antigen Levels

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.